- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 5 mg dapagliflozin / 1000 mg metformin XR FDC
Total 213 results
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Romania, Canada, Russian Federation, Czech Republic, Slovakia, Mexico
-
International Bio serviceNot yet recruiting
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus
-
Solvay PharmaceuticalsCompletedDiabetes Mellitus, Type 2 | DyslipidemiaFrance
-
University of Campinas, BrazilAstraZenecaCompletedCoronary Artery Disease | Diabetes Mellitus, Type 2 | Carotid Artery DiseasesBrazil
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
IPCA Laboratories Ltd.Completed
-
Uppsala UniversityUppsala University Hospital; Swedish Healthcare Regions; Swedish National Board... and other collaboratorsActive, not recruitingType 2 DiabetesSweden
-
University Hospital TuebingenTerminatedType 2 DiabetesGermany
-
Merck Sharp & Dohme LLCTerminated
-
IPCA Laboratories Ltd.Completed
-
Ranbaxy Laboratories LimitedCompleted
-
AIO-Studien-gGmbHTaiho Pharmaceutical Co., Ltd.; Nordic Pharma SASCompletedEsophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm | Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionGermany
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
Dexa Medica GroupCompletedMetformin XR BE Study in Healthy Volunteers With Single and Multiple DoseIndonesia
-
Merck Sharp & Dohme LLCPfizerActive, not recruitingType 2 Diabetes MellitusUnited States, Belgium, Canada, Colombia, Costa Rica, Dominican Republic, France, Guatemala, Hungary, Israel, Italy, Malaysia, Mauritius, Mexico, Philippines, Poland, Russian Federation, Saudi Arabia, Turkey, Ukraine, United Arab... and more
-
Idorsia Pharmaceuticals Ltd.CompletedPharmacokinetics | Pharmacodynamics | Tolerability | SafetyNetherlands
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Tanta UniversityNot yet recruitingBreast Cancer Female
-
GlaxoSmithKlineCompleted
-
German University in CairoRecruiting
-
CelltrionCompleted
-
Dallas VA Medical CenterOtsuka Pharmaceutical Development & Commercialization, Inc.UnknownHelicobacter InfectionUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
GlaxoSmithKlineHammersmith Medicines Research; Covance HarrogateCompletedHypertension, PulmonaryUnited Kingdom
-
Jinnah Postgraduate Medical CentreNot yet recruitingNon-Alcoholic Fatty Liver Disease | Type2diabetesPakistan
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalUnknown
-
Khyber Medical University PeshawarCompleted
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell CancerFrance, Italy, Spain, Germany, Hungary, Austria, Switzerland, Belgium, Poland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Khyber Medical University PeshawarCompleted
-
Merck Sharp & Dohme LLCPfizerCompleted
-
University of BasrahRecruiting
-
SINA Health Education and Welfare TrustHorizon Pharmaceutical Pvt LtdCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Hypoglycemic Agents | EmpagliflozinPakistan
-
Boryung Pharmaceutical Co., LtdCompleted
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Joint Stock Company "Farmak"Completed
-
Janssen Research & Development, LLCCompleted
-
Beni-Suef UniversityMinia UniversityCompletedDiabetes Mellitus, Type 2Egypt
-
Hoffmann-La RocheCompletedColorectal CancerFrance, Israel, Italy, Spain, Sweden, Hong Kong, Australia, Canada, Switzerland, United States, Ireland, Denmark, Germany, Taiwan, Russian Federation, China, New Zealand, Austria, United Kingdom, Hungary, Thailand, South Africa, Mexico and more
-
All India Institute of Medical Sciences, BhubaneswarNot yet recruitingDifference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Women and Children's Health... and other collaboratorsSuspendedPolycystic Ovary Syndrome | Lipid Metabolism DisordersCanada